FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W1511299470> ?p ?o ?g. }

• W1511299470 abstract "Immunohistochemical assessment of proliferation may provide additional prognostic information in early breast cancer. However, due to a lack of methodological standards proliferation markers are still not routinely used for determining therapy. Even for Ki67, one of the most widely-studied markers, disagreements over the optimal cutoff exist. Improvements in digital microscopy may provide new avenues to standardise and make data more reproducible. We studied the immunohistochemical expression of three markers of proliferation: Ki67, Mini-Chromosome Maintenance protein 2 and Geminin, by conventional light microscope and digital imaging on triplicate TMAs from 309 consecutive cases of primary breast cancers. Differences between the average and the maximum percentage reactivity in tumour cell nuclei from the three TMA cores were investigated to assess the validity of the approach. Time-dependent Receiver Operating Characteristic curves were utilized to obtain optimal expression level cut-offs, which were then correlated with clinico-pathological features and survival. High concordance between conventional and digital scores was observed for all 3 markers (Ki67: rs = 0.87, P < 0.001; MCM2: rs = 0.94, P < 0.001; and Geminin: rs = 0.86, P < 0.001; Spearman’s rank). There was no significant difference according to the number of TMA cores included for either Ki67 or MCM2; analysis of two or three cores produced comparable results. Higher levels of all three proliferation markers were significantly associated with higher grade (P < 0.001) and ER-negativity (P < 0.001). Optimal prognostic cut-offs for percentage expression in the tumour were 8 %, 12 and 2.33 % for Ki67, MCM2 and Geminin respectively. All 3 proliferation marker cutoffs were predictive of 15-year breast cancer-specific survival in univariable Cox regression analyses. In multivariable analysis only lymph node status (HR = 3.9, 95 % CI = 1.79-8.5, P = 0.0006) and histological grade (HR = 1.84, 95 % CI = 1–3.38, P = 0.05) remained significantly prognostic. Here we show that. MCM2 is a more sensitive marker of proliferation than Ki67 and should be examined in future studies, especially in the lymph node-negative, hormone receptor-positive subgroup. Further, digital microscopy can be used effectively as a high-throughput method to evaluate immunohistochemical expression." @default.
• W1511299470 created "2016-06-24" @default.
• W1511299470 creator A5034034892 @default.
• W1511299470 creator A5054103832 @default.
• W1511299470 creator A5055005629 @default.
• W1511299470 creator A5055450638 @default.
• W1511299470 creator A5058414510 @default.
• W1511299470 creator A5058969643 @default.
• W1511299470 creator A5085942558 @default.
• W1511299470 date "2015-07-25" @default.
• W1511299470 modified "2023-10-16" @default.
• W1511299470 title "Digital imaging in the immunohistochemical evaluation of the proliferation markers Ki67, MCM2 and Geminin, in early breast cancer, and their putative prognostic value" @default.
• W1511299470 cites W134095429 @default.
• W1511299470 cites W1513618424 @default.
• W1511299470 cites W1521381579 @default.
• W1511299470 cites W1966571450 @default.
• W1511299470 cites W1969141148 @default.
• W1511299470 cites W1981989535 @default.
• W1511299470 cites W1987183852 @default.
• W1511299470 cites W2001968322 @default.
• W1511299470 cites W2003124695 @default.
• W1511299470 cites W2012845106 @default.
• W1511299470 cites W2024792080 @default.
• W1511299470 cites W2029925140 @default.
• W1511299470 cites W2033944657 @default.
• W1511299470 cites W2039017973 @default.
• W1511299470 cites W2045631017 @default.
• W1511299470 cites W2047267829 @default.
• W1511299470 cites W2049427909 @default.
• W1511299470 cites W2056715763 @default.
• W1511299470 cites W2058602228 @default.
• W1511299470 cites W2065710674 @default.
• W1511299470 cites W2109242212 @default.
• W1511299470 cites W2112130196 @default.
• W1511299470 cites W2113217165 @default.
• W1511299470 cites W2117692326 @default.
• W1511299470 cites W2127057139 @default.
• W1511299470 cites W2129781454 @default.
• W1511299470 cites W2131994307 @default.
• W1511299470 cites W2137935883 @default.
• W1511299470 cites W2139537685 @default.
• W1511299470 cites W2140628034 @default.
• W1511299470 cites W2148806969 @default.
• W1511299470 cites W2150134401 @default.
• W1511299470 cites W2152121590 @default.
• W1511299470 cites W2155803397 @default.
• W1511299470 cites W2158169271 @default.
• W1511299470 cites W2159489835 @default.
• W1511299470 cites W2160780418 @default.
• W1511299470 cites W2164738119 @default.
• W1511299470 cites W2168197820 @default.
• W1511299470 cites W2177928620 @default.
• W1511299470 cites W2186745337 @default.
• W1511299470 cites W2348374435 @default.
• W1511299470 cites W4239915479 @default.
• W1511299470 doi "https://doi.org/10.1186/s12885-015-1531-3" @default.
• W1511299470 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/4513675" @default.
• W1511299470 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/26205655" @default.
• W1511299470 hasPublicationYear "2015" @default.
• W1511299470 type Work @default.
• W1511299470 sameAs 1511299470 @default.
• W1511299470 citedByCount "32" @default.
• W1511299470 countsByYear W15112994702016 @default.
• W1511299470 countsByYear W15112994702017 @default.
• W1511299470 countsByYear W15112994702018 @default.
• W1511299470 countsByYear W15112994702019 @default.
• W1511299470 countsByYear W15112994702020 @default.
• W1511299470 countsByYear W15112994702021 @default.
• W1511299470 countsByYear W15112994702022 @default.
• W1511299470 countsByYear W15112994702023 @default.
• W1511299470 crossrefType "journal-article" @default.
• W1511299470 hasAuthorship W1511299470A5034034892 @default.
• W1511299470 hasAuthorship W1511299470A5054103832 @default.
• W1511299470 hasAuthorship W1511299470A5055005629 @default.
• W1511299470 hasAuthorship W1511299470A5055450638 @default.
• W1511299470 hasAuthorship W1511299470A5058414510 @default.
• W1511299470 hasAuthorship W1511299470A5058969643 @default.
• W1511299470 hasAuthorship W1511299470A5085942558 @default.
• W1511299470 hasBestOaLocation W15112994701 @default.
• W1511299470 hasConcept C121608353 @default.
• W1511299470 hasConcept C126322002 @default.
• W1511299470 hasConcept C142724271 @default.
• W1511299470 hasConcept C143998085 @default.
• W1511299470 hasConcept C160798450 @default.
• W1511299470 hasConcept C204232928 @default.
• W1511299470 hasConcept C207886595 @default.
• W1511299470 hasConcept C2780140570 @default.
• W1511299470 hasConcept C2909546088 @default.
• W1511299470 hasConcept C530470458 @default.
• W1511299470 hasConcept C58471807 @default.
• W1511299470 hasConcept C71924100 @default.
• W1511299470 hasConceptScore W1511299470C121608353 @default.
• W1511299470 hasConceptScore W1511299470C126322002 @default.
• W1511299470 hasConceptScore W1511299470C142724271 @default.
• W1511299470 hasConceptScore W1511299470C143998085 @default.
• W1511299470 hasConceptScore W1511299470C160798450 @default.
• W1511299470 hasConceptScore W1511299470C204232928 @default.
• W1511299470 hasConceptScore W1511299470C207886595 @default.
• W1511299470 hasConceptScore W1511299470C2780140570 @default.
• W1511299470 hasConceptScore W1511299470C2909546088 @default.

• next